Please login to view and cast your EC vote.

Xiaojie Chen  
Business Development Manager
1996 PhD, Institute of Neuroscience, University of Alicante, Spain.
1984 BSc, Department of Biology, Nanjing University, China.
2020 - present Business Development Manager, TargetMol Chemicals, Wellesley Hills, MA
2014 - present Scientific Consultant, AfaSci Inc, Redwood City, CA
2018 - 2020 District Sales Manager, MedChemExpress LLC, Monmouth Junction, NJ
2017 - 2017 Sales Manager, Selleck Chemicals, LLC, Houston, TX
2014 - 2016 Vice President/Principal Scientist, Gateway Biotechnology, Inc, Rootstown, OH
2009 - 2013 Associate Researcher, University of California, San Francisco, CA
1999 - 2009 Assistant Researcher, University of California, San Francisco, CA
1984 - 1992 Investigator/Teacher, Suzhou Medical College, China
Prior CABS Service
AMC member 2022
Election Statement
My name is Xiaojie Chen. I have made ongoing contributions to biological research, drug and business development for thirty years.
Now I am working for TargetMol as Business Development Manager. I would like to contribute my knowledge and time to promote Sino-US collaborations, especially in the Chinese Community of Bay Area as a CABS EC Member.
Thank you very much for your consideration
Benjamin Chen  
Panacea Venture
Benjamin is a scientist, entrepreneur, investor and merchant banker. Most recently Benjamin served as the CEO of ImaginAb, Inc. a ventured backed company developing a cutting-edge platform to address an urgent unmet need in immuno-oncology. Immediately before that, he was the Chairman and CEO of London based Immune Targeting Systems, Inc. leading the immune therapy company through significant strategic growth, innovative product development and establishing a presence in France and North America. Prior to returning to operational roles, he spent nine years as a Managing Director at Burrill & Company, a global life sciences venture firm where he evaluated investment opportunities and assisted a global clientele in completing licensing, partnering and M&A transactions. He also played a key role in establishing the Malaysian Life Sciences Fund I and served as a director. Earlier in his career as an R&D executive, he has experience in building talented research team in immunology, stem cell biology, genomics, gene therapy and molecular diagnostics in both biotechnology start-ups and multinational pharmaceutical companies including Roche Diagnostics and Novartis.
Ben received his academic training in Microbiology and Immunology at the University of Wisconsin-Madison and Stanford University. Benjamin resides in the San Francisco Bay Area.
Prior CABS Service
Election Statement
I'd like to mentor the next generation entreprenurs.
yu chen  陈宇
Health Science Specialist
Palo Alto Veterans Institute for Research
BA Beijing Medical University 1983-1989
Phd Beijing Medical University 1989-1995
Basic Life Science Scientist 2004-2014
Health Science Specialist 2014-present
Prior CABS Service
Election Statement
Xi Fang  
Managing Partner
Dr. Xi Fang is a Founding Partner of Button, an investment firm focusing on Health Care. Dr. Fang has been serving the International Collaboration Committee as a co-chair since 2022.
Prior CABS Service
co-chair of the International Collaboration Committee
Election Statement
Wenjia Gu  顾文嘉
Research Scientist
Wenjia obtained her bachelor’s degree in Chemistry from Zhejiang University in 2014. She then went to the University of Utah and studied natural product enzymes and biochemistry, and published 11 publications on high impact journals. She received her Ph.D. degree in Medicinal Chemistry in 2021, and joined Zymergen Inc as a research scientist, working on synthetic biology and biochemistry.
Prior CABS Service
I volunteered at the 2022 BioPacific conference in the speaker interview team. I prepared the questionnaires, and interviewed the speakers with two other team members.
Election Statement
I enjoyed my time as a volunteer during the CABS BioPacific conference. During the preparation and volunteering time, I felt the passion from the active members and participants to progress the field, as well as to increase the Chinese/Asian people's impact. I also felt it was a great opportunity to connect with more people in the field, and learn more from them. Besides, I learned a lot by observing organizing process. By directly interviewing the speakers, volunteers and participants, I was very happy to see that it turned to be a really successful event. In the future, I would love to further participate in more activities, and contribute to the community. I'm interested in many of the EC Committee positions, and I sincerely hope that you could consider my application.
Guanghui Han  
Dr. Guanghui Han currently is the Senior Director of Mass Spectrometry Center in San Jose at BGI Americas Corporation. Dr. Han received his post-doctoral training at Johns Hopkins School of Medicine in Dr. Gerald Hart’s group. His research was focused on understanding the role of O-GlcNAcylation in disease, a modification discovered in the Hart lab, and specifically worked on methods for enrichment and detection of the modification in kinases and their roles in the crosstalk between glycosylation and phosphorylation. In 2014, Dr. Han joined Genentech Inc, where his role as a scientific manager was to develop and apply MS based technologies for characterization of therapeutic molecules. In 2018, Dr. Han helped found the Mass Spectrometry Center in San Jose at BGI Americas Corporation to provide high quality Mass Spec service for customers with a special focus on the Mass Spec assays (including but not limited to Biologics Characterization, Quantitative Proteomics and Metabolomics) to accelerate drug R&D with by using state-of-the-art Mass Spectrometers. Dr. Guanghui Han has published more than 40 papers in a variety of international journals, including Nature, Molecular cell, Molecular & Cellular Proteomics, Analytical Chemistry, mAbs, with over 3000 citations.
Prior CABS Service
Election Statement
Liang He  贺亮
Dr. Liang He is a postdoc at UCSF. Liang received his Ph.D. from the Institute of Biophysics, University of Chinese Academy of Science, and doing his postdoctoral training at the Department of Cellular Molecular Pharmacology, UCSF. He has over 10 years of virology study experience focusing on virus and host interaction, aiming to inhibit emerging virus replication. Liang utilizes molecular biochemistry, immunology, and cell biology method to study how the host factors inhibit the virus lifecycle. Now he is developing new methods/systems to better study virology at UCSF, using biosensors/reporters, and animal models of diseases. In his spare time, He likes running, hiking, playing basketball, and biking.
Prior CABS Service
Liang has served as a volunteer of PRC (2022), and most recently AMC (2022) since he joined CABS in 2021. He actively served on the Organizing Committee of the 2022 BioPacific Conference, which was successfully held in November 2022.
Election Statement
service, is always making things working well.
Ella Li  
Founder & CEO
M7 Healthcare Accelerator
Dr. Ella Li is the founder of M7 Healthcare Accelerator, providing 3-months-acceleration services to healthcare startups for each cohort. She is also a venture partner of Network VC, focusing on seed to series A investment in the healthcare sector. She also serves the role as the CEO of Hanhai BioLabs, leading the team in life science investment and globalization to transform healthcare. Dr. Li is the former CEO of ZGC Capital and the partner of its U.S. funds. She has established and managed several VC and fund of funds; including one with portfolio funds including KPCB, Menlo, Andreessen Horowitz, Accel, Foundation Capital, and IVP.

Dr. Li has over 15 years of experience in biotech research and has rich experiences in therapeutic investment opportunities from discovery and clinical proof-of-concept to commercialization. She also serves as a board advisor, consultant, and advisor for several global accelerators, VCs and startups. Dr. Ella Li earned her B.S. and M.S. degrees from Peking University, and her Ph.D. from the University of Texas Health Science Centers. She completed her postdoctoral fellowship from Harvard Medical School, where she led five independent projects exploring novel therapeutic targets for metabolic disease. Dr. Li has extensive publications in over 10 prestigious journals with IMF some of which include Nature Communication, Cell Metabolism, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences (PNAS), Molecular Cell, and Diabetes with 900 citations.
Prior CABS Service
Election Statement
Danielle Liu  刘丹
Based in San Francisco Bay Area, Danielle Liu is a well-rounded Human Resources Advisor and business leader with global and cross-function, multi-sector experiences. A Lifetime learner with strong curiosity and entrepreneurial spirit. Danielle also provides executive assessment & leadership development consulting and accelerated integration support to executives transitioning to new roles.

Danielle has more than 20 years of experience in transnational human resource management, helping industries such as internet finance, healthcare, banking, retail, and supply chain. She has special expertise in building and leading top-performing teams, turning around troubled organizations, and establishing HR functions from scratch, as well as establishing HR global platform, particular leading the development and business landing of Chinese companies in North America, and helping them become public.

In recent years, Danielle was the Vice President of Human Resources at Vcredit Group and helped the company successfully get listed in the Hong Kong Stock Market. She was also the former Director of Human Resources in Asia at Home Depot and the Human Resources Director at Deutsche Bank China. Furthermore, she served in Fortune 500 pharmaceutical companies like Eli Lilly and Merck, taking on various leadership roles in Human Resources.

Born and raised in China, Danielle graduated from the China Europe International Business School (CEIBS) and holds a master's degree in business administration. She speaks fluent Chinese and English. The mother of three children, she is passionate about family, friends, and travel. Danielle also does volunteer work helping newly graduated college students with their career development.

“I really believe that leadership is a journey, and my passion is helping leaders unlock their unique potential, build teams, and pilot organizations.”
Prior CABS Service
BCD Member in 2022
Election Statement
In the past year, I participated in some CABS work and was in charge of the CAN Program. It is a really enjoyable and rewarding experience to work with the CABS team. I hope to continue contributing to this society.
Vivian Bing Liu  
Director of operation and managements
Education background:
I Acquired a Ph.D in basic medicine in Peking Union Medical College in 2015. However, the major of my bachelor and master was pharmacology. Therefore, I am good at deal with the transdisciplinary project or task.
Career pathway:
I worked as product manager in Novogene China from 2015-2018 and transferred to be a director of operation and managements in Novogene US from 2018.
So far, I worked in PRC and AMC in CABS since Sep in 2022.
Prior CABS Service
Conference volunteer
Election Statement
My name is Vivian (Bing) Liu. I already participated in the preparation of CABS annual meeting in 2022. Be in charge of the preparation of one workshop in noon session as sub-chair. be highly passionate with volunteer service in CABS. Please vote for me. Thanks.
Lu Lu  
Senior Director of Business Development
WuXi AppTec
Lu currently works at WuXi AppTec as Senior Director of Business Development. Prior to that, she worked in a few biotech startups in Bay Area. She has been volunteering in CABS since 2017 and most recently as co-chair of PRC in 2022. Lu holds a master's degree from Auburn University in Biological Engineering.
Prior CABS Service
Co-chair PRC 2022
Various volunteer experience since 2017
Election Statement
It was a great pleasure to work with CABS family for science and social life events. I look forward to continuing to contribute to wherever needed.
zhiyun luo  罗志云
Market Manager
Please see CV
Prior CABS Service
Election Statement
Liping Meng  
Senior Research Scientist
Gilead Sciences
Ph.D., Organic Chemistry, University of Tuebingen, Germany
M.S., Organic Chemistry, Central China Normal University, China
B.S. Chemistry, Central China Normal University, China

Senior Research Scientist, Gilead Sciences
Senior Chemist, AnaSpec
Postdoctoral Researcher, University of California at Davis

Awards and professional affiliations:
• Key Contributor Award at Gilead Sciences
• Member of The American Association of Pharmaceutical Scientists (AAPS)
• Member of American Chemical Society
• Member of CABS
Prior CABS Service
She has been serving in CABS committees since 2011, including as Co-chair of Membership Committee 2015-2017 and Co-chair of Business and Career Development Committee 2018-2022.
Election Statement
“As we work to create light for others, we naturally light our own way.” I would like to take this election opportunity to continue to build strong platform for CABS members, interact with our members, and greatly contribute to the growth of CABS.
Suping Ren  任苏平
Lab Manager
Janssen Research and Development
Prior CABS Service
2020-2022: PRC EC member
2020: Social life EC member
Election Statement
I would like to make some contributions to CABS and serve the community.
Hesong Sun  
VP Product Development and Operations
ARC Medical Inc
Received BSc and PhD from the University of Toronto in 2013. Progressed from Bioassay Scientist in 2016 to Manager of Preclinical in 2018 and VP of Product Development and Operations in 2019.
Prior CABS Service
2022 Volunteer of the CABS STC Committee
2022 Co-chair of the CABS ICC Committee
2022 BioPacific Conference Volunteer and Co-chair of Morning Session I
Election Statement
I find CABS to be an extremely helpful community with lots of colleagues in similar fields. I would love to continue to serve the community by donating my time and skills to help organize events throughout the year. Thank you for your consideration.
Kay Tong  
Quality through Compliance. Over 20 years of management experience in Pharmaceutical and Medical Devices companies including areas of Research, Manufacturing, Quality Control, and Quality Assurance. Implemented global policies and programs which have resulted in successful regulatory inspections and approvals.
Prior CABS Service
BCD Co-Chair
Election Statement
I would like to leverage my experience in mentoring and networking to help develop others and create opportunities for others to collaborate and be mentored.
Yan Wang  
Chempartner US
Professional Experience
2015 – present Senior Scientist, Principal Scientist, Director, Department of Peptide Chemistry, ChemPartner
2010 – 2011, Postdoctoral Fellow, Stanford University
2006 – 2010, Postdoctoral Fellow, University of California, Davis

Professional Experience
2015 – present Senior Scientist, Principal Scientist, Director Department of Peptide Chemistry, ChemPartner
Prior CABS Service
STC CoChair @2022
PRC member @2020-2021
Volunteer for CABS events for 3-5 years
Election Statement
The CABS volunteer team is a friendly, supportive and encouraging team. When we volunteered to work for CABS, we also got many opportunities to develop ourselves and network. It was my first time organizing a scientific seminar on antibody drug manufacturing. It was my first time being a moderator of a panel discussion at a conference with a few hundred attendees. I knew many people who work in different biotech companies, attorneys, and VCs all over the bay area. I want to continue volunteering at CABS and have fun with friends together.
Yanan Wang  王亚男
Associate Director
Ab Studio
My name is Yanan Wang and I am Associate Director at Ab Studio. I received my Ph.D. from Shanghai Jiao Tong University in Shanghai, China in 2015, and completed postdoctoral training at Fudan University in 2018 and Stanford University in 2020. I joined my current company in 2021 and focus on therapeutic antibody discovery and assay development.
Prior CABS Service
Election Statement
Yu Yang  杨宇
Hanhai Silicon Valley Center
Yu Yang is the CEO of Hanhai Silicon Valley Center.
Prior CABS Service
Election Statement
Zhiyong Yang  
I am an immunologist currently working in the Department of Discovery Immunology at Genentech. Before that I was a specialist at UCSF. I got my bachelor degree from Wuhan Univerity, PhD from Chinese Academy of Sciences, and postdoc trainings from Mount Sinai School of Medicine and Baylor College of Medicine.
I have been the president of Association of Chinese Students and Scholars at UCSF from 2013-2015.
Prior CABS Service
2022 EC member at AMC, lead of 2022 BioPacific Program Book
2014 EC member at MEM
2013 EC Member at PRC
Member and volunteer since 2008.
Election Statement
I have been a loyal member and volunteer of CABS since 2008. By serving for the CABS community, I have been rewarded with new skills, connections and friendships. It would be my great honor to continue serving the CABS community with my extensive expertise in research in both academia and industry, and a long track record of community services.
Alex Yang  
Senior Scientist
Vir Biotechnology
Professional Experience

Vir Biotechnology, San Francisco Nov. 2021 – present
Senior Scientist

Staidson Biopharma, San Francisco Bay Area Nov. 2019 – Aug. 2021
Senior Scientist (In charge of antibody discovery team)

The Scripps Research Institute (TSRI), San Diego, CA (USA) Nov. 2016 – Oct. 2019
Staff Scientist
• Served as principal investigator for a San Diego Center for AIDS Research Developmental Grant, NIH
• Co-authored 4 publications on Immunity, Cell Reports, Nature Immunology, and Frontiers in Immunology

University of Washington, Seattle, WA (USA) Nov. 2012 – Oct.2016
Research Associate


Ph.D. in Microbiology, 2012
Institut Pasteur of Shanghai (IPS), Chinese Academy of Sciences (CAS), Shanghai, China
Co-authored 4 publications of VLP development and antibody engineering on J Virol, Vaccines; Filed 1 patent application; Presented research at 5 national and 1 international conferences
B.S. in Biological Sciences, 2006
East China University of Science & Technology (ECUST), Shanghai, China

Grant and Awards

• 2019 San Diego Center for AIDS Research (SD CFAR) Developmental Grant, NIH
• 2015 Young Investigator Scholarship, 22nd Conference on Retroviruses and Opportunistic Infections
• 2013 Pfizer Scholarship
• 2011 Conference Scholarship at AIDS Vaccine 2011, Bangkok, Thailand
• 2010 Excellent Student Awards of CAS
Prior CABS Service
Volunteered in the STC team in 2022
Participated in the organizing committee for the 23rd annual conference of CABS
Election Statement
I am passionate in science & technology, and business & career development. I would like to work more closely with the EC committees to make the CABS better. If given the opportunity, I will try my best to learn and to contribute.
Wang Yaqiang  
Principal Scientist
Arrakis Therapeutics
2000-2004 BS Huazhong University of Science and Technology
2004-2007 MS Chinese Academy of Sciences
2007-2012 PhD University of North Carolina at Chapel Hill

2012-2021 Postdoc University of California Los Angeles
2021-present Principal Scientist Arrakis Therapeutics
Prior CABS Service
Election Statement
I would like to continue to help CABS to organize events.
Huijun Zhou  周慧君
Stanford University
Dr. Huijun Zhou received her PhD in molecular biology and genetics from Cornell University and completed her post-doctoral medical genetics training at Stanford University School of Medicine. She is a clinical molecular geneticist and board-certified by the American Board of Medical Genetics.

Dr Zhou is an experienced biotech entrepreneur and executive. Previously she worked at Incyte Pharmaceuticals and DNA Direct in Silicon Valley. She has cofounded and advised several biotech startups in Silicon Valley and mentored many first-time entrepreneurs.

Currently, Dr Zhou is an adjunct Professor at Department of Medicine, Stanford University. She teaches courses and mentors Stanford Graduate School of Business students and Knight-Hennessy Scholars. She also conducts research on precision medicine.
Prior CABS Service
CABS Entrepreneurship Club Chair
Election Statement
I hope to continue to serve the CABS Entrepreneurship Club. We hope to :
1. Help entrepreneurs in the CABS community
2. Fostering entrepreneurship and innovation cultures
3. Bring together investors, entrepreneurs and service professionals
Jack Zhu  朱宁
Senior director of business development
Porton Advanced Solutions
Jack Zhu is currently senior director of business development at Porton Advanced Solutions, a cell and gene CDMO company. Before this, Jack worked for several other CDMO companies such as WuXi AppTec and Analytical Biosciences in commercial roles including business development and commercial operations. Jack has a solid understanding of how the biopharma, especially cell and gene focus companies operate commercially. Jack has a master engineering degree and a MBA.
Prior CABS Service
Business and career development
Election Statement
In 2023 I would like to continue to contribute in the BCD department. Seeing the popularity and benefit of the CAN program in 2022, I am encouraged to do it again in 2023 and push it to the next level. My network resource and experiences gained in 2022 will serve well for me to continue the contribution in BCD.